Karina Dalsgaard Sørensen

Promoter hypomethylation and upregulation of trefoil factors in prostate cancer

Research output: Contribution to journal/Conference contribution in journal/Contribution to newspaperJournal articleResearchpeer-review

  • Clinical Biochemistry
  • Department of clinical biochemistry
  • The Department of Urology K
  • Molekylær medicinsk afdeling (MOMA)
Trefoil factors, mucin-associated peptides, are overexpressed in prostate cancer (PC). We hypothesized that promoter methylation contributes to the regulation of trefoil factors (TFF1, TFF2 and TFF3) in human prostate cells. Here we show hypomethylation of promoter regions of TFF1 and TFF3 in PC cell lines with significant TFF expression as compared to benign immortalized prostate cell lines and PC cell lines not expressing trefoil factor. The most striking difference was observed for CpG sites located close to the AUG start codon overlapping several putative binding sites for cellular transcription factors. TFF2 was hypermethylated and had no or very low expression in all prostate cell lines investigated. Treatment of methylated cell lines with 5-aza-2'-deoxycytidine restored TFF expression in cell lines not expressing TFF and increased expression significantly in low-expressing cell lines. In clinical samples, methylation of the promoter/enhancer regions of TFF1 and TFF3 was significantly lower in PC compared to benign prostatic hyperplasia. The present study shows an inverse relation between promoter methylation and expression of trefoil factors. Preliminary analysis on clinical samples suggests that this regulatory mechanism is responsible for the increased levels of TFF1 and TFF3 observed in PC. The overexpression and promoter hypomethylation of trefoil factors may serve as biomarkers in PC.
Original languageEnglish
JournalInternational Journal of Cancer
Pages (from-to)1857-65
Number of pages8
Publication statusPublished - 2010

    Research areas

  • Adenocarcinoma, DNA Methylation, Gene Expression Regulation, Neoplastic, Humans, Male, Peptides, Prognosis, Promoter Regions, Genetic, Prostatic Hyperplasia, Prostatic Neoplasms, Tumor Cells, Cultured, Tumor Markers, Biological, Tumor Suppressor Proteins, Up-Regulation

See relations at Aarhus University Citationformats

ID: 20681585